Cholesterol and cardiovascular disease: no longer whether, but rather when, in whom, and how?
1985; Lippincott Williams & Wilkins; Volume: 72; Issue: 4 Linguagem: Inglês
10.1161/01.cir.72.4.686
ISSN1524-4539
Autores Tópico(s)Inflammatory mediators and NSAID effects
ResumoHomeCirculationVol. 72, No. 4Cholesterol and cardiovascular disease: no longer whether, but rather when, in whom, and how? Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBCholesterol and cardiovascular disease: no longer whether, but rather when, in whom, and how? R I Levy R I LevyR I Levy Originally published1 Oct 1985https://doi.org/10.1161/01.CIR.72.4.686Circulation. 1985;72:686–691 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Paar W (2016) Frühere Zulassung von Arzneimitteln - Eine Chance für Patienten?, Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 10.1016/j.zefq.2016.04.010, 112, (S27-S33), . Raczynski J, Phillips M, Cornell C, Gilliland M, Sanderson B and Bittner V (1999) Cardiovascular Diseases Handbook of Health Promotion and Disease Prevention, 10.1007/978-1-4615-4789-1_12, (231-259), . Coppola G, Damon R and Engstrom R SYNTHESIS OF A CON FORMATIONALLY RESTRAINED 4-ARYLTHIOPHENE-3-HEPTENOIC ACID AND ITS EVALUATION AS AN HMG COENZYME A REDUCTASE INHIBITOR, Heterocyclic Communications, 10.1515/HC.1998.4.2.105, 4:2 Kuhlmann J, Mück W, Bischoff H, Keutz E and Llewellyn M (1998) Cerivastatin (BAY w 6228): A Novel HMG-CoA Reductase Inhibitor, Cardiovascular Drug Reviews, 10.1111/j.1527-3466.1998.tb00357.x, 16:3, (236-263), Online publication date: 1-Sep-1998. Tang Y, Jones L and Sunay U (1998) Synthesis of carbon-14 labeled fluvastatin (Lescol®), Journal of Labelled Compounds and Radiopharmaceuticals, 10.1002/(SICI)1099-1344(199801)41:1 3.0.CO;2-B, 41:1, (1-7), Online publication date: 1-Jan-1998. SMITH D, STERNDORFF B, RØPCKE G, GUSTAVSEN E and HANSEN J (1996) Prevalence and severity of anxiety, depression and Type A behaviors in angina pectoris, Scandinavian Journal of Psychology, 10.1111/j.1467-9450.1996.tb00657.x, 37:3, (249-258), Online publication date: 1-Sep-1996. Lau E, Woo J, Cockram C, Chan A, Lam C, Swaminathan R and Donnan S (1993) Serum lipid profile and its association with some cardiovascular risk factors in an urban chinese population, Pathology, 10.3109/00313029309090854, 25:4, (344-350), . Chapleur Y (1993) The Chemistry and Total Synthesis of Mevinolin and Related Compounds Recent Progress in the Chemical Synthesis of Antibiotics and Related Microbial Products Vol. 2, 10.1007/978-3-642-78250-3_17, (829-937), . Kathawala F (1991) HMG‐CoA Reductase Inhibitors: An Exciting Development in the Treatment of Hyperlipoproteinemia, Medicinal Research Reviews, 10.1002/j.1098-1128.1991.tb00001.x, 11:2, (121-146), Online publication date: 1-Mar-1991. Wilson M (1991) Cholesterol reduction in the workplace and in community settings, Journal of Community Health, 10.1007/BF01340468, 16:1, (49-65), Online publication date: 1-Feb-1991. STERNDORFF B and SMITH D (1990) Normal values for Type A behaviour patterns in Danish men and women and in potential high-risk groups, Scandinavian Journal of Psychology, 10.1111/j.1467-9450.1990.tb00801.x, 31:1, (49-54), Online publication date: 1-Mar-1990. Brewer H (1989) Clinical significance of plasma lipid levels, The American Journal of Cardiology, 10.1016/0002-9149(89)90949-1, 64:13, (G3-G9), Online publication date: 1-Oct-1989. Levy R and Blum C (1989) What are the Comparative Risks versus Benefits for Bile Acid Sequestrants, HMG Co-A Reductase Inhibitors, Nicotinic Acid, Probucol, and Fibric Acid Derivatives? Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents, 10.1007/978-1-4613-1605-3_13, (215-223), . Pauciullo P, Rubba P, Marotta G, Carbone C, Cortese C, Caruso M, Spampinato N and Mancini M (1988) Abnormalities in serum lipoprotein composition in patients with premature coronary heart disease compared to serum lipid matched controls, Atherosclerosis, 10.1016/0021-9150(88)90047-0, 73:2-3, (241-246), Online publication date: 1-Oct-1988. Levy R (2016) Currently Available Lipid-Lowering Agents, Hospital Practice, 10.1080/21548331.1988.11703634, 23:sup1, (14-21), Online publication date: 1-Jun-1988. BROHET C, JANSSENS D, BECK D, HANNUT R, KULBERTUS H, LAVENNE F, LEFEBVRE P, RORIVE G and JEANJEAN M (2009) Cardiovascular risk factors in a sample of a rural Belgian population: The Bellux MONICA Study, Acta Medica Scandinavica, 10.1111/j.0954-6820.1988.tb05564.x, 224:S728, (129-136) Lee J, Rowe V, Thatcher C, D.V.M. D and Saunders^D.V.M. G (1988) High dietary NaCl increases cholesterol and coronary atherosclerosis in cholesterol-fed rabbits, Nutrition Research, 10.1016/S0271-5317(88)80035-6, 8:4, (413-419), Online publication date: 1-Apr-1988. Naito H (2016) Reducing cardiac deaths with hypolipidemic drugs, Postgraduate Medicine, 10.1080/00325481.1987.11700033, 82:6, (102-112), Online publication date: 1-Nov-1987. Weinstein D and Heider J (1987) Antiatherogenic properties of calcium antagonists, The American Journal of Cardiology, 10.1016/0002-9149(87)90097-X, 59:3, (B163-B172), Online publication date: 1-Jan-1987. Doorey A, Michelson E, Weber F and Dreifus L (1987) Thrombolytic therapy of acute myocardial infarction: Emerging challenges of implementation, Journal of the American College of Cardiology, 10.1016/S0735-1097(87)80141-9, 10:6, (1357-1360), Online publication date: 1-Dec-1987. Stinshoff K, Stein W, Wood W and Laska P (2002) Clinical chemistry, Analytical Chemistry, 10.1021/ac00139a018, 59:12, (337-350), Online publication date: 15-Jun-1987. Newton R and Krause B (1986) Chapter 19. Approaches to Drug Intervention in Atherosclerotic Disease , 10.1016/S0065-7743(08)61129-X, (189-200), . Christensen R and Kirkham A (2021) Time-Restricted Eating: A Novel and Simple Dietary Intervention for Primary and Secondary Prevention of Breast Cancer and Cardiovascular Disease, Nutrients, 10.3390/nu13103476, 13:10, (3476) October 1, 1985Vol 72, Issue 4 Advertisement Article InformationMetrics Copyright © 1985 by American Heart Associationhttps://doi.org/10.1161/01.CIR.72.4.686 Originally publishedOctober 1, 1985 PDF download Advertisement
Referência(s)